Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

Intermittent cyclical therapy with etidronate for two years significantly increases spinal bone mass and reduces the incidence of new vertebral fractures in women with postmenopausal osteoporosis.